TGE Value Creative Solutions Corp. (BEBE)
10.05
0.00 (0.00%)
USD |
NYSE |
Oct 12, 16:00
TGE Value Creative Solutions Enterprise Value : 200.56M for Oct. 12, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 12, 2026 | 200.56M |
| October 09, 2026 | 200.56M |
| October 08, 2026 | 200.56M |
| October 07, 2026 | 200.56M |
| October 06, 2026 | 200.56M |
| October 05, 2026 | 200.56M |
| October 02, 2026 | 200.36M |
| October 01, 2026 | 200.36M |
| September 30, 2026 | 200.36M |
| September 29, 2026 | 200.36M |
| September 28, 2026 | 200.36M |
| September 25, 2026 | 200.36M |
| September 24, 2026 | 200.36M |
| September 23, 2026 | 200.36M |
| September 22, 2026 | 200.36M |
| September 21, 2026 | 200.36M |
| September 18, 2026 | 200.36M |
| September 17, 2026 | 200.36M |
| September 16, 2026 | 200.36M |
| September 15, 2026 | 200.36M |
| September 14, 2026 | 200.56M |
| September 11, 2026 | 200.16M |
| September 10, 2026 | 199.16M |
| September 09, 2026 | 199.16M |
| September 08, 2026 | 199.16M |
| Date | Value |
|---|---|
| September 04, 2026 | 199.16M |
| September 03, 2026 | 199.16M |
| September 02, 2026 | 199.16M |
| September 01, 2026 | 199.16M |
| August 31, 2026 | 199.16M |
| August 28, 2026 | 199.16M |
| August 27, 2026 | 199.36M |
| August 26, 2026 | 199.36M |
| August 25, 2026 | 200.36M |
| August 24, 2026 | 200.36M |
| August 21, 2026 | 199.36M |
| August 20, 2026 | 199.56M |
| August 19, 2026 | 199.56M |
| August 18, 2026 | 199.56M |
| August 17, 2026 | 199.56M |
| August 14, 2026 | 199.56M |
| August 13, 2026 | 199.56M |
| August 12, 2026 | 199.56M |
| August 11, 2026 | 199.16M |
| August 10, 2026 | 199.16M |
| August 07, 2026 | 199.16M |
| August 06, 2026 | 199.16M |
| August 05, 2026 | 199.16M |
| August 04, 2026 | 199.16M |
| August 03, 2026 | 199.16M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Sanofi | 105.72B |
| DBV Technologies SA | 352.30M |
| Cellectis SA | 56.26M |
| Innate Pharma SA | -- |
| Inventiva SA | 685.80M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 1.362M |
| Total Expenses (Quarterly) | -1.362M |
| EPS Diluted (Quarterly) | 0.0681 |
| Earnings Yield | 1.41% |
| Normalized Earnings Yield | 1.413 |